![NEORELIEF FOR MUSCLE CRAMPLING AND RESTLESSNESS topical gel for muscle cramping 4 [hp_X]/g; 8 [hp_X]/g; 4 [hp_X]/g; 4 [hp_X]/g; 4 [hp_X]/g; 4 [hp_X]/g; 4 [hp_X]/g Gel, 56.7 g — NDC 58368-0002-02 package photo](https://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=46da3f0e-9dd1-6495-e054-00144ff8d46c&name=NeoRelief_MuscleCramping2oz.jpg)
NEORELIEF FOR MUSCLE CRAMPLING AND RESTLESSNESS topical gel for muscle cramping 4 [hp_X]/g; 8 [hp_X]/g; 4 [hp_X]/g; 4 [hp_X]/g; 4 [hp_X]/g; 4 [hp_X]/g; 4 [hp_X]/g Gel, 56.7 g
by BioLyte Laboratories, LLC · 56.7 g in 1 BOTTLE, PUMP (58368-002-02)
NDC 58368-0002-02
🏷️ FDA NDC (as labeled)
58368-002-02
billing pads the product segment with a zero
OTC
On market
Non-controlled
🗂️ Data synced Sep 17, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
58368-002-02
Product NDC
58368-002
11-digit billing NDC
58368000202
UNII
DD5FO1WKFU, J0F5GM8LA8, 1LZ13MQR0S, N94C2U587S, O80TY208ZW, 6MW97Q6E8M +12 more
SPL Set ID
46da3f0e-9dd1-6495-e054-00144ff8d46c
DEA schedule
Non-controlled
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2017-02-01
Route
TOPICAL
Dosage form
GEL
Substance
CAUSTICUM; JATROPHA CURCAS SEED; FRANGULA CALIFORNICA BARK; RUTA GRAVEOLENS FLOWERING TOP; ARNICA MONTANA; ATROPA BELLADONNA ROOT; BLACK COHOSH; ARTEMISIA CINA PRE-FLOWERING TOP; PSEUDOGNAPHALIUM OBTUSIFOLIUM; HYPERICUM PERFORATUM; STRYCHNOS IGNATII SEED;
Why two NDCs?
The FDA registers this code as 58368-002-02 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 58368-0002-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏭 Manufacturer & labeler
LabelerBioLyte Laboratories, LLC
Labeler code58368
First marketedFeb 2017
Product typeHuman Otc Drug
Portfolio4 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
🧪 What is this product?
Neorelief for Muscle Crampling and Restlessness is a topical gel marketed as a homeopathic product. It contains multiple plant-derived and mineral substances that are used in homeopathic practice, including arnica, ruta, hypericum, belladonna, and black cohosh, among others. These ingredients are traditionally used in homeopathic preparations for complaints related to muscle discomfort and restlessness. Homeopathic products are marketed based on homeopathic tradition and are not evaluated by the FDA for effectiveness.
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about topical gel for muscle cramping and restlessness?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Neorelief For Muscle Crampling And Restlessness 4 [hp_X]/g; 8 [hp_X]/g; 4 [hp_X]/g; 4 [hp_X]/g; 4 [hp_X]/g; 4 [hp_X]/g; 4 [hp_X]/gthis 58368-0002-02 | BioLyte | 56.7 g | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2017
On the market since
Feb 2017
📍
2026
Currently FDA-listed
9 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 58368-0002-02 You're viewing this | 56.7 g in 1 BOTTLE, PUMP (58368-002-02) | 2017-02-01 | Active |
🧭 About this NDC listing & data coverage
Over-the-counter (OTC) product
Homeopathic listing
About homeopathic listings
NEORELIEF FOR MUSCLE CRAMPLING AND RESTLESSNESS topical gel for muscle cramping 4 [hp_X]/g; 8 [hp_X]/g; 4 [hp_X]/g; 4 [hp_X]/g; 4 [hp_X]/g; 4 [hp_X]/g; 4 [hp_X]/g GEL is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Homeopathic". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 58368-002-02, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 58368-0002-02, written without dashes as 58368000202. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 58368-0002-02, the first segment (58368) is the labeler code FDA assigned to BioLyte Laboratories, LLC; the middle segment (0002) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (02) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by BioLyte Laboratories, LLC. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
BioLyte Laboratories, LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Uses For temporary relief of occasional muscle cramps, restlessness and twitching
⏱️ Dosage and Administration ▾
Directions Adults and children 2 years of age and older, apply a thin layer of gel on clean skin to cover the affected area. For best results, allow gel to be absorbed into the skin; do not rub in. Apply at the onset of symptoms, not more than 6 times daily or every 15 minutes for the first hour. Do not use with other topical remedies or lotions.
⚠️ Warnings ▾
Warnings For external use only Do not use on damaged or broken skin. Keep out of eyes, open wounds, mucous membranes
📦 Storage and Handling ▾
Other Information Store in a cool, dry place Avoid direct sunlight Tamper-evident for your protection. Use only if safety seal is intact.
🧪 Active Ingredient ▾
Drug Facts Active Ingredients All active ingredients are HPUS* Arncia 4X, Causticum 4X, Rhamnus Calif. 4X, Ruta 4X, Taraxacum 4X, Belladonna 4X, Cimicifuga 4X, Gnaphalium 4X, Hypericum Perf. 4X, Jatropha 8X, Veratrum 8X Cina 8X, Ignatia 4X, Kali Brom. 4X, Kali Carb. 4X, Lycopodium 4X, Scutellaria 4X, Valeriana Off. 4X *HPUS indicates the active ingredients are in the official Homeopathic Pharmacopeia of the United States. NeoRelief Muscle Cramp
🧪 Inactive Ingredients ▾
Inactive Ingredients Citric Acid, Fulvic acid, Glycerin, Potassium Sorbate, Purified Water, Sodium Hydroxide, Ultrez-10 Polymer
🎯 Purpose ▾
Purpose For the temporary relief of occasional: Muscle cramps, restlessness, twiching Indications are based on homeopathic materia medica, not clinical tests.
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.